132 related articles for article (PubMed ID: 22215905)
1. The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology.
Pollak M
Clin Cancer Res; 2012 Jan; 18(1):40-50. PubMed ID: 22215905
[TBL] [Abstract][Full Text] [Related]
2. Insulin, insulin-like growth factors and neoplasia.
Pollak M
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):625-38. PubMed ID: 18971123
[TBL] [Abstract][Full Text] [Related]
3. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
Ozkan EE
Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions.
Gualberto A; Pollak M
Oncogene; 2009 Aug; 28(34):3009-21. PubMed ID: 19581933
[TBL] [Abstract][Full Text] [Related]
5. Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.
Hendrickson AW; Haluska P
Curr Opin Investig Drugs; 2009 Oct; 10(10):1032-40. PubMed ID: 19777391
[TBL] [Abstract][Full Text] [Related]
6. Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.
Hubbard RD; Bamaung NY; Fidanze SD; Erickson SA; Palazzo F; Wilsbacher JL; Zhang Q; Tucker LA; Hu X; Kovar P; Osterling DJ; Johnson EF; Bouska J; Wang J; Davidsen SK; Bell RL; Sheppard GS
Bioorg Med Chem Lett; 2009 Mar; 19(6):1718-21. PubMed ID: 19217287
[TBL] [Abstract][Full Text] [Related]
7. Minireview: Were the IGF Signaling Inhibitors All Bad?
Beckwith H; Yee D
Mol Endocrinol; 2015 Nov; 29(11):1549-57. PubMed ID: 26366975
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.
Ryan PD; Goss PE
Oncologist; 2008 Jan; 13(1):16-24. PubMed ID: 18245009
[TBL] [Abstract][Full Text] [Related]
9. Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies.
Yap TA; Olmos D; Molife LR; de Bono JS
Expert Opin Investig Drugs; 2011 Sep; 20(9):1293-304. PubMed ID: 21777167
[TBL] [Abstract][Full Text] [Related]
10. Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.
Sangha R; Lara PN; Mack PC; Gandara DR
Curr Opin Oncol; 2009 Mar; 21(2):116-23. PubMed ID: 19532012
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H; Wesseling J; Boezen HM; van der Graaf WT
Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
[TBL] [Abstract][Full Text] [Related]
12. Targeting insulin-like growth factor 1 receptor in sarcomas.
Scotlandi K; Picci P
Curr Opin Oncol; 2008 Jul; 20(4):419-27. PubMed ID: 18525338
[TBL] [Abstract][Full Text] [Related]
13. IGF1R signalling and its inhibition.
Riedemann J; Macaulay VM
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S33-43. PubMed ID: 17259557
[TBL] [Abstract][Full Text] [Related]
14. Targeting insulin and insulin-like growth factor signalling in oncology.
Pollak M
Curr Opin Pharmacol; 2008 Aug; 8(4):384-92. PubMed ID: 18674638
[TBL] [Abstract][Full Text] [Related]
15. The insulin and insulin-like growth factor receptor family in neoplasia: an update.
Pollak M
Nat Rev Cancer; 2012 Feb; 12(3):159-69. PubMed ID: 22337149
[TBL] [Abstract][Full Text] [Related]
16. Targeting the insulin-like growth factor axis for the development of novel therapeutics in oncology.
Gao J; Chang YS; Jallal B; Viner J
Cancer Res; 2012 Jan; 72(1):3-12. PubMed ID: 22215692
[TBL] [Abstract][Full Text] [Related]
17. The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy.
Bähr C; Groner B
Growth Horm IGF Res; 2004 Aug; 14(4):287-95. PubMed ID: 15231297
[TBL] [Abstract][Full Text] [Related]
18. Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.
Scotlandi K; Benini S; Nanni P; Lollini PL; Nicoletti G; Landuzzi L; Serra M; Manara MC; Picci P; Baldini N
Cancer Res; 1998 Sep; 58(18):4127-31. PubMed ID: 9751624
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.
Tao Y; Pinzi V; Bourhis J; Deutsch E
Nat Clin Pract Oncol; 2007 Oct; 4(10):591-602. PubMed ID: 17898809
[TBL] [Abstract][Full Text] [Related]
20. Targeting the insulin-like growth factor receptor.
Yee D
Clin Adv Hematol Oncol; 2009 Jul; 7(7):452-4. PubMed ID: 19701152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
